JP2015500342A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500342A5
JP2015500342A5 JP2014547445A JP2014547445A JP2015500342A5 JP 2015500342 A5 JP2015500342 A5 JP 2015500342A5 JP 2014547445 A JP2014547445 A JP 2014547445A JP 2014547445 A JP2014547445 A JP 2014547445A JP 2015500342 A5 JP2015500342 A5 JP 2015500342A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pva
particle
composition
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014547445A
Other languages
English (en)
Japanese (ja)
Other versions
JP6216721B2 (ja
JP2015500342A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/069585 external-priority patent/WO2013090634A1/en
Publication of JP2015500342A publication Critical patent/JP2015500342A/ja
Publication of JP2015500342A5 publication Critical patent/JP2015500342A5/ja
Application granted granted Critical
Publication of JP6216721B2 publication Critical patent/JP6216721B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014547445A 2011-12-14 2012-12-13 粒子を凍結乾燥または凍結するためのポリマー賦形剤の使用 Active JP6216721B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161570735P 2011-12-14 2011-12-14
US61/570,735 2011-12-14
PCT/US2012/069585 WO2013090634A1 (en) 2011-12-14 2012-12-13 Use of polymeric excipients for lyophilization or freezing of particles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017183764A Division JP2017218462A (ja) 2011-12-14 2017-09-25 粒子を凍結乾燥または凍結するためのポリマー賦形剤の使用

Publications (3)

Publication Number Publication Date
JP2015500342A JP2015500342A (ja) 2015-01-05
JP2015500342A5 true JP2015500342A5 (cg-RX-API-DMAC7.html) 2016-01-28
JP6216721B2 JP6216721B2 (ja) 2017-10-18

Family

ID=48613191

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014547445A Active JP6216721B2 (ja) 2011-12-14 2012-12-13 粒子を凍結乾燥または凍結するためのポリマー賦形剤の使用
JP2017183764A Pending JP2017218462A (ja) 2011-12-14 2017-09-25 粒子を凍結乾燥または凍結するためのポリマー賦形剤の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017183764A Pending JP2017218462A (ja) 2011-12-14 2017-09-25 粒子を凍結乾燥または凍結するためのポリマー賦形剤の使用

Country Status (25)

Country Link
US (3) US9585960B2 (cg-RX-API-DMAC7.html)
EP (2) EP2790675B1 (cg-RX-API-DMAC7.html)
JP (2) JP6216721B2 (cg-RX-API-DMAC7.html)
KR (2) KR102203555B1 (cg-RX-API-DMAC7.html)
CN (2) CN109771377A (cg-RX-API-DMAC7.html)
AU (2) AU2012352167B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014014323A2 (cg-RX-API-DMAC7.html)
CA (1) CA2858593C (cg-RX-API-DMAC7.html)
CY (1) CY1122105T1 (cg-RX-API-DMAC7.html)
DK (1) DK2790675T3 (cg-RX-API-DMAC7.html)
ES (1) ES2746057T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20191567T1 (cg-RX-API-DMAC7.html)
HU (1) HUE045661T2 (cg-RX-API-DMAC7.html)
IL (1) IL233000B (cg-RX-API-DMAC7.html)
LT (1) LT2790675T (cg-RX-API-DMAC7.html)
ME (1) ME03532B (cg-RX-API-DMAC7.html)
MX (2) MX374915B (cg-RX-API-DMAC7.html)
PL (1) PL2790675T3 (cg-RX-API-DMAC7.html)
PT (1) PT2790675T (cg-RX-API-DMAC7.html)
RS (1) RS59322B1 (cg-RX-API-DMAC7.html)
RU (2) RU2705998C2 (cg-RX-API-DMAC7.html)
SI (1) SI2790675T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900502T1 (cg-RX-API-DMAC7.html)
WO (1) WO2013090634A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201404262B (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
SI2301531T1 (sl) 2005-02-18 2018-11-30 Abraxis Bioscience, Llc Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
LT2117520T (lt) 2006-12-14 2018-12-10 Abraxis Bioscience, Llc Krūties vėžio terapija hormonų receptoriaus statuso pagrindu su nanodalelėmis, apimančiomis taksaną
KR20120044279A (ko) 2009-04-15 2012-05-07 아브락시스 바이오사이언스, 엘엘씨 무-프리온 나노입자 조성물 및 방법
BR112012024349A2 (pt) 2010-03-26 2016-05-24 Abraxis Bioscience Llc métodos de tratamento de carcinoma hepatocelular
RU2016119999A (ru) 2010-03-29 2018-11-08 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Способы лечения онкологических заболеваний
CN105147613A (zh) 2010-03-29 2015-12-16 阿布拉科斯生物科学有限公司 增强药物递送和治疗剂有效性的方法
EP2575804A4 (en) 2010-06-04 2013-10-23 Abraxis Bioscience Llc METHOD FOR THE TREATMENT OF PANCREASCRE
WO2012149451A1 (en) 2011-04-28 2012-11-01 Abraxis Bioscience, Llc Intravascular delivery of nanoparticle compositions and uses thereof
RU2705998C2 (ru) 2011-12-14 2019-11-13 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Применение полимерных эксципиентов для лиофилизации или заморозки частиц
US9149455B2 (en) 2012-11-09 2015-10-06 Abraxis Bioscience, Llc Methods of treating melanoma
US9511046B2 (en) 2013-01-11 2016-12-06 Abraxis Bioscience, Llc Methods of treating pancreatic cancer
ES2804323T3 (es) 2013-03-12 2021-02-05 Abraxis Bioscience Llc Procedimientos de tratamiento de cáncer de pulmón
CN105246468A (zh) 2013-03-14 2016-01-13 阿布拉科斯生物科学有限公司 治疗膀胱癌的方法
US10527604B1 (en) 2015-03-05 2020-01-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
US10705070B1 (en) 2015-03-05 2020-07-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
AU2016285720C1 (en) 2015-06-29 2022-02-03 Abraxis Bioscience, Llc Methods of treating epithelioid cell tumors
SG11202009145PA (en) 2018-03-20 2020-10-29 Abraxis Bioscience Llc Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin
US20210196568A1 (en) * 2018-05-21 2021-07-01 Chugai Seiyaku Kabushiki Kaisha Lyophilized formulation sealed in glass container
RU2681933C1 (ru) * 2018-11-28 2019-03-14 Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" Способ получения полимерных противоопухолевых частиц в проточном микрореакторе и лиофилизата на их основе
WO2021086946A1 (en) 2019-10-28 2021-05-06 Abraxis Bioscience, Llc Pharmaceutical compositions of albumin and rapamycin
IL300519A (en) 2020-08-14 2023-04-01 Arcturus Therapeutics Inc Method for lyophilization of lipid nanoparticles
WO2024046448A1 (en) * 2022-09-02 2024-03-07 Suzhou Abogen Biosciences Co., Ltd. Lyophilized formulations and liquid formulations of lipid nanoparticles
WO2024077054A1 (en) * 2022-10-05 2024-04-11 Purdue Research Foundation Excipient-free lyophilization of polymer lung surfactants

Family Cites Families (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2018734A1 (de) 1970-04-18 1971-10-28 Agfa-Gevaert Ag, 5090 Leverkusen Photographisches Verfahren
BR9405798A (pt) 1993-02-22 1995-12-12 Vivorx Pharmaceuticals Inc Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
US5665382A (en) 1993-02-22 1997-09-09 Vivorx Pharmaceuticals, Inc. Methods for the preparation of pharmaceutically active agents for in vivo delivery
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5665383A (en) 1993-02-22 1997-09-09 Vivorx Pharmaceuticals, Inc. Methods for the preparation of immunostimulating agents for in vivo delivery
US5650156A (en) 1993-02-22 1997-07-22 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of nutriceuticals and compositions useful therefor
US5997904A (en) 1993-02-22 1999-12-07 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US6096331A (en) 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5916596A (en) 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
US5362478A (en) 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US20030068362A1 (en) 1993-02-22 2003-04-10 American Bioscience, Inc. Methods and formulations for the delivery of pharmacologically active agents
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US6528067B1 (en) 1993-02-22 2003-03-04 American Bioscience, Inc. Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
DE59409568D1 (de) * 1993-09-09 2000-11-30 Schering Ag Wirkstoffe und gas enthaltende mikropartikel
US6565842B1 (en) 1995-06-07 2003-05-20 American Bioscience, Inc. Crosslinkable polypeptide compositions
US6537539B2 (en) 1996-01-11 2003-03-25 Human Genome Sciences, Inc. Immune cell cytokine
US7368129B1 (en) * 1996-08-14 2008-05-06 Nutrimed Biotech Amphiphilic materials and liposome formulations thereof
US20070092563A1 (en) 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US20030199425A1 (en) 1997-06-27 2003-10-23 Desai Neil P. Compositions and methods for treatment of hyperplasia
NZ502500A (en) 1997-06-27 2002-03-28 Vivorx Pharmaceuticals Inc Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
ATE313259T1 (de) * 1998-09-21 2006-01-15 21St Century Medicine Inc Verbesserte kälteschutzlösungen
KR100321854B1 (ko) * 1998-12-30 2002-08-28 동국제약 주식회사 루테이나이징 호르몬 릴리싱 호르몬 동족체를 함유하는 장기 서방출성 미립구 및 그의 제조방법
EP1171117A4 (en) 1999-04-22 2002-08-07 American Bioscience Inc LONG-TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS
AU784416B2 (en) 1999-05-21 2006-03-30 Abraxis Bioscience, Llc Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
AR023940A1 (es) * 2000-05-03 2002-09-04 Eriochem Sa Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
ITMI20001107A1 (it) 2000-05-18 2001-11-18 Acs Dobfar Spa Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
RU2291686C2 (ru) 2000-12-13 2007-01-20 Меркле Гмбх Микрочастицы с улучшенным профилем высвобождения и способ их изготовления
US8137699B2 (en) 2002-03-29 2012-03-20 Trustees Of Princeton University Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
JP2003012505A (ja) 2001-07-06 2003-01-15 Nano Career Kk 薬物含有高分子ミセルの凍結乾燥
ITMI20020680A1 (it) 2002-03-29 2003-09-29 Acs Dobfar Spa Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
ITMI20020681A1 (it) 2002-03-29 2003-09-29 Acs Dobfar Spa Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
CN1398585A (zh) * 2002-07-15 2003-02-26 裴福兴 一种bFGF－PLA－PEG缓释微球及其制备方法和用途
KR20110079741A (ko) 2002-12-09 2011-07-07 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
JP4851067B2 (ja) * 2004-01-28 2012-01-11 ホソカワミクロン株式会社 ナノ粒子含有組成物およびその製造方法
US8735394B2 (en) 2005-02-18 2014-05-27 Abraxis Bioscience, Llc Combinations and modes of administration of therapeutic agents and combination therapy
US20070166388A1 (en) 2005-02-18 2007-07-19 Desai Neil P Combinations and modes of administration of therapeutic agents and combination therapy
SI2301531T1 (sl) 2005-02-18 2018-11-30 Abraxis Bioscience, Llc Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija
JP2006321763A (ja) * 2005-05-20 2006-11-30 Hosokawa Funtai Gijutsu Kenkyusho:Kk 生体適合性ナノ粒子及びその製造方法
CA2620389C (en) 2005-08-31 2014-06-17 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
PL3311805T3 (pl) 2005-08-31 2020-07-27 Abraxis Bioscience, Llc Kompozycje zawierające słabo rozpuszczalne w wodzie środki farmaceutyczne i środki przeciwdrobnoustrojowe
WO2008027288A2 (en) * 2006-08-30 2008-03-06 The Trustees Of Columbia University In The City Of New York Treatment for craniosynostosis by growth factor delivery
US20080280987A1 (en) 2006-08-31 2008-11-13 Desai Neil P Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
CA2662140A1 (en) 2006-08-31 2008-03-06 Abraxis Bioscience, Llc Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
LT2117520T (lt) 2006-12-14 2018-12-10 Abraxis Bioscience, Llc Krūties vėžio terapija hormonų receptoriaus statuso pagrindu su nanodalelėmis, apimančiomis taksaną
MX380318B (es) 2007-03-07 2025-03-12 Abraxis Bioscience Llc Nanoparticula que comprende rapamicina y albumina como agente anticancer.
US20100166869A1 (en) 2007-05-03 2010-07-01 Desai Neil P Methods and compositions for treating pulmonary hypertension
AU2008260447B2 (en) 2007-06-01 2013-10-10 Abraxis Bioscience, Llc Methods and compositions for treating recurrent cancer
CA2721153C (en) 2008-04-10 2018-10-02 Abraxis Bioscience, Llc Compositions of hydrophobic taxane derivatives and uses thereof
KR20100133475A (ko) 2008-04-10 2010-12-21 아브락시스 바이오사이언스, 엘엘씨 소수성 탁산 유도체의 조성물 그의 용도
NZ593343A (en) 2008-12-11 2013-04-26 Abraxis Bioscience Llc Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
WO2010068899A1 (en) 2008-12-12 2010-06-17 Creighton University Nanoparticles comprising combinations of antiretroviral agents and use thereof
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
KR101739598B1 (ko) 2009-03-13 2017-06-08 아브락시스 바이오사이언스, 엘엘씨 티오콜키신 유도체와의 조합 요법
EA201171195A8 (ru) * 2009-03-30 2014-08-29 Серулин Фарма Инк. Конъюгаты, частицы, композиции "полимер-агент" и способы их применения
AU2010233097B2 (en) 2009-04-10 2016-04-07 Abraxis Bioscience, Llc Nanoparticle formulations and uses thereof
KR20120044279A (ko) 2009-04-15 2012-05-07 아브락시스 바이오사이언스, 엘엘씨 무-프리온 나노입자 조성물 및 방법
SG10201609290PA (en) 2009-08-25 2016-12-29 Abraxis Bioscience Llc Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
EP2509634B1 (en) * 2009-12-11 2019-03-06 Pfizer Inc Stable formulations for lyophilizing therapeutic particles
US20110237686A1 (en) 2010-03-26 2011-09-29 Cerulean Pharma Inc Formulations and methods of use
BR112012024349A2 (pt) 2010-03-26 2016-05-24 Abraxis Bioscience Llc métodos de tratamento de carcinoma hepatocelular
CN105147613A (zh) 2010-03-29 2015-12-16 阿布拉科斯生物科学有限公司 增强药物递送和治疗剂有效性的方法
RU2016119999A (ru) 2010-03-29 2018-11-08 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Способы лечения онкологических заболеваний
EP2575803B1 (en) 2010-06-02 2017-07-26 Abraxis BioScience, LLC Methods of treating bladder cancer
EP2575804A4 (en) 2010-06-04 2013-10-23 Abraxis Bioscience Llc METHOD FOR THE TREATMENT OF PANCREASCRE
US20140155344A1 (en) 2010-06-07 2014-06-05 Neil P. Desai Combination therapy methods for treating proliferative diseases
CA2808901A1 (en) * 2010-08-20 2012-02-23 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
WO2012149451A1 (en) 2011-04-28 2012-11-01 Abraxis Bioscience, Llc Intravascular delivery of nanoparticle compositions and uses thereof
RU2705998C2 (ru) 2011-12-14 2019-11-13 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Применение полимерных эксципиентов для лиофилизации или заморозки частиц
US9149455B2 (en) 2012-11-09 2015-10-06 Abraxis Bioscience, Llc Methods of treating melanoma
US20140186447A1 (en) 2012-12-28 2014-07-03 Abraxis Bioscience, Llc Nanoparticle compositions of albumin and paclitaxel
US9511046B2 (en) 2013-01-11 2016-12-06 Abraxis Bioscience, Llc Methods of treating pancreatic cancer
US20140199404A1 (en) 2013-01-11 2014-07-17 Abraxis Bioscience, Llc Method for treating cancer based on level of a nucleoside transporter
US20140199405A1 (en) 2013-01-11 2014-07-17 Abraxis Bioscience, Llc Method for treating cancer based on mutation status of k-ras
WO2014123612A1 (en) 2013-02-11 2014-08-14 Abraxis Bioscience, Llc Methods of treating melanoma
ES2804323T3 (es) 2013-03-12 2021-02-05 Abraxis Bioscience Llc Procedimientos de tratamiento de cáncer de pulmón
HK1219231A1 (zh) 2013-03-13 2017-03-31 阿布拉科斯生物科学有限公司 治疗儿童实体瘤的方法
CN105246468A (zh) 2013-03-14 2016-01-13 阿布拉科斯生物科学有限公司 治疗膀胱癌的方法
US20170202782A1 (en) 2014-04-06 2017-07-20 Abraxis Bioscience, Llc Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for treating cancer
WO2016141365A1 (en) 2015-03-05 2016-09-09 Abraxis Bioscience, Llc Method for treating cancer based on level of glucocorticoid receptor
NZ738929A (en) 2015-06-29 2024-01-26 Abraxis Bioscience Llc Methods of treating solid tumors using nanoparticle mtor inhibitor combination therapy
MX2017016519A (es) 2015-06-29 2018-08-16 Abraxis Bioscience Llc Biomarcadores para composiciones de nanoparticulas.
AU2016285720C1 (en) 2015-06-29 2022-02-03 Abraxis Bioscience, Llc Methods of treating epithelioid cell tumors
EA201890159A1 (ru) 2015-06-29 2018-11-30 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи СПОСОБЫ ЛЕЧЕНИЯ ГЕМАТОЛОГИЧЕСКОГО ЗЛОКАЧЕСТВЕННОГО НОВООБРАЗОВАНИЯ С ПОМОЩЬЮ КОМБИНИРОВАННОЙ ТЕРАПИИ ИНГИБИТОРОМ mTOR В ВИДЕ НАНОЧАСТИЦ
US20170181988A1 (en) 2015-12-23 2017-06-29 Cipla Limited Methods for the treatment of bladder cancer
US20190147986A1 (en) 2016-05-17 2019-05-16 Abraxis Bioscience, Llc Methods for assessing neoadjuvant therapies
CN109996527A (zh) 2016-10-10 2019-07-09 阿布拉科斯生物科学有限公司 纳米颗粒制剂及其制备和使用方法
US20180374583A1 (en) 2017-05-16 2018-12-27 Abraxis Bioscience, Llc Nomogram and survival predictions for pancreatic cancer
JP2021506839A (ja) 2017-12-19 2021-02-22 アブラクシス バイオサイエンス， エルエルシー ナノ粒子ｍＴＯＲ阻害剤併用治療を使用して結腸がんを処置する方法

Similar Documents

Publication Publication Date Title
JP2015500342A5 (cg-RX-API-DMAC7.html)
RU2014128590A (ru) Применение полимерных эксципиентов для лиофилизации или заморозки частиц
Meyer et al. Biomimetic particles as therapeutics
Gupta et al. Possible role of nanocarriers in drug delivery against cervical cancer
US11684585B2 (en) Nanoscale coatings for encapsulation of biological entities
JP2011520813A5 (cg-RX-API-DMAC7.html)
Keegan et al. Biodegradable microspheres with enhanced capacity for covalently bound surface ligands
JP2011525477A5 (cg-RX-API-DMAC7.html)
Ramachandran et al. Synthesis and characterization of PEGylated calcium phosphate nanoparticles for oral insulin delivery
JP2016504362A5 (cg-RX-API-DMAC7.html)
JP2013530158A5 (cg-RX-API-DMAC7.html)
JP2014530219A5 (cg-RX-API-DMAC7.html)
JP2017535581A5 (cg-RX-API-DMAC7.html)
JP2011157405A5 (cg-RX-API-DMAC7.html)
JP2011503213A5 (cg-RX-API-DMAC7.html)
JP2016511747A5 (cg-RX-API-DMAC7.html)
Wu et al. Preparation and evaluation of amoxicillin loaded dual molecularly imprinted nanoparticles for anti-Helicobacter pylori therapy
CN103432100A (zh) 基于聚乙二醇及叶酸接枝的聚乙烯亚胺改性的plga载药空心微囊的制备方法
Blanco-Prıeto et al. In vitro evaluation of gentamicin released from microparticles
CN105343015A (zh) 具有双淋巴靶向的抗肿瘤药物载体制备方法
Paolicelli et al. Surface-modified PLGA-based nanoparticles that can efficiently associate and deliver virus-like particles
JP2019534897A5 (cg-RX-API-DMAC7.html)
Debnath et al. Potential application of bionanoparticles to treat severe acute respiratory syndrome coronavirus-2 infection
CN110354072A (zh) 一种近红外光响应的氧化石墨烯/凹凸棒石复合超分子水凝胶的制备和应用
JP2018505805A5 (cg-RX-API-DMAC7.html)